HOME PRODUCTS COMPANY CONTACT FAQ

Research Dictionary Pharma

Sign Up FREE or Login

isopropyl 5,12- hydroxypentadeca- 8,10- dien- 6,14- diynoate

the isopropyl ester prodrug of RX-10008

Also Known As:

RX-10045

Networked: 2 relevant articles (0 outcomes, 0 trials/studies)

Bio-Agent Context: Research Results

Experts

1.	Chiosi, Flavia: 1 article (01/2016)
2.	Costagliola, Ciro: 1 article (01/2016)
3.	Hesselink, Jan M Keppel: 1 article (01/2016)
4.	Agrawal, Vandana: 1 article (01/2014)
5.	Santhanam, Abirami: 1 article (01/2014)
6.	Torricelli, Andre A M: 1 article (01/2014)
7.	Wilson, Steven E: 1 article (01/2014)

Related Diseases

1.	Dry Eye Syndromes (Dry Eye Syndrome) 01/01/2016 - "We also briefly investigate the concept of aliamides and the role of palmitoylethanolamide in ophthalmology, and analyze in more detail the putative role and the preclinical and clinical development of resolvins as emerging treatments for dry eye and related disorders, with a focus on one of the lead resolvin derivatives - RX-10045."
2.	Corneal Opacity 01/01/2014 - "Corneal opacity was significantly lower in the 0.1% RX-10045 group, but not the 0.01% RX-10045 group, compared to the vehicle control group (p=0.029), at 1 month after -9.0D PRK. " 01/01/2014 - "Topical 0.1% RX-10045, a prodrug of an RvE1 analog, reduces corneal opacity after haze-generating PRK in rabbits. "

Related Drugs and Biologics

1.	Prodrugs
2.	5S,12R,18R- trihydroxy- 6Z,8E,10E,14Z,16E- eicosapentaenoic acid
3.	palmidrol